YAPALI, S. Et Al. 2021. Real Life Efficacy and Tolerability of Tenofovir Alafenamide Fumarate in Patients with Hepatitis B Virus-related Cirrhosis and Liver Transplant Recipients. A-Preliminary Result (798). AASLD the Liver Meeting Digital Experience , (United States Of America), 490.

YAPALI, S., GÖKCAN, H., HARPUTLUOĞLU, M. M. M., MELEKOĞLU ELLİK, Z., AKARSU, M., DURAK, S., ... GÖKÇEN, P.(2021). Real Life Efficacy and Tolerability of Tenofovir Alafenamide Fumarate in Patients with Hepatitis B Virus-related Cirrhosis and Liver Transplant Recipients. A-Preliminary Result (798) . AASLD the Liver Meeting Digital Experience (pp.490). , United States Of America

YAPALI, SUNA Et Al. "Real Life Efficacy and Tolerability of Tenofovir Alafenamide Fumarate in Patients with Hepatitis B Virus-related Cirrhosis and Liver Transplant Recipients. A-Preliminary Result (798)," AASLD the Liver Meeting Digital Experience, United States Of America, 2021

YAPALI, SUNA Et Al. "Real Life Efficacy and Tolerability of Tenofovir Alafenamide Fumarate in Patients with Hepatitis B Virus-related Cirrhosis and Liver Transplant Recipients. A-Preliminary Result (798)." AASLD the Liver Meeting Digital Experience , United States Of America, pp.490, 2021

YAPALI, S. Et Al. (2021) . "Real Life Efficacy and Tolerability of Tenofovir Alafenamide Fumarate in Patients with Hepatitis B Virus-related Cirrhosis and Liver Transplant Recipients. A-Preliminary Result (798)." AASLD the Liver Meeting Digital Experience , United States Of America, p.490.

@conferencepaper{conferencepaper, author={SUNA YAPALI Et Al. }, title={Real Life Efficacy and Tolerability of Tenofovir Alafenamide Fumarate in Patients with Hepatitis B Virus-related Cirrhosis and Liver Transplant Recipients. A-Preliminary Result (798)}, congress name={AASLD the Liver Meeting Digital Experience}, city={}, country={United States Of America}, year={2021}, pages={490} }